Evaluation of incidence and risk factors for brachytherapy-induced Complications in uveal melanoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00019049

Enrollment

4900

Registered

2019-10-21

Start date

2019-10-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C69.3 H15.8

Interventions

Group 1: We aimed to perform a retrospective analysis of data from patients’ electronic health records. A intervention is not intended.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis: uveal melanoma Therapy: brachytherapy Time intervall: 1/1999-12/2016

Exclusion criteria

Exclusion criteria: Patients with uveal melanoma, managed with other therapieoptions like: primary enucleation or protom beam radiation

Design outcomes

Primary

Measure	Time frame
To assess incidence and risk factors different brachytherapy-induced complications.	—

Secondary

Measure	Time frame
Funkctional outcome, tumor control	—

Countries

Germany

Contacts

Public ContactLeyla Jabbarli

Universitätsklinikum Essen, Augenklinik

leyla.jabbarli@uk-essen.de02017232900

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026